{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:37:04Z","timestamp":1785620224267,"version":"3.56.0"},"reference-count":26,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary adrenal insufficiency (PAI) is often the first clinical sign of X-linked adrenoleukodystrophy (X-ALD), a rare genetic disorder that can present with various clinical phenotypes. A subset of boys with X-ALD develop cerebral ALD (cALD), characterized by progressive central demyelination, neurocognitive decline, and ultimately death. Timely intervention with hematopoietic cell transplant (HCT) can be a life-saving therapy by stopping progression of cerebral disease. We report the case of an 11-year-old boy with type 1 diabetes mellitus who presented with PAI, growth delay, and symptoms of attention deficit hyperactivity disorder. Given his history of T1DM, his PAI was presumed to be autoimmune and he was started on hydrocortisone and fludrocortisone. Eleven months later brain magnetic resonance imaging revealed white matter hyperintensity consistent with advanced cALD. The degree of disease progression at the time of diagnosis rendered the patient ineligible for transplant and he has continued to experience progressive neurologic decline. Initial symptoms of cALD are often subtle but should not be overlooked, as early identification of X-ALD is critical to allow early intervention with lifesaving HCT. PAI typically presents prior to the onset of neurologic symptoms. All boys who present with PAI should undergo workup for X-ALD with plasma very long chain fatty acid testing, even in the setting of underlying autoimmune disease.<\/jats:p>","DOI":"10.1210\/jendso\/bvac039","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:38:08Z","timestamp":1649770688000},"source":"Crossref","is-referenced-by-count":5,"title":["Primary Adrenal Insufficiency in a Boy with Type I Diabetes: The Importance of Considering X-linked Adrenoleukodystrophy"],"prefix":"10.1210","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-8091","authenticated-orcid":false,"given":"Rebecca E","family":"Wiersma","sequence":"first","affiliation":[{"name":"University of Minnesota Pediatric Residency Program, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish O","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy C","family":"Lund","sequence":"additional","affiliation":[{"name":"Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-3629","authenticated-orcid":false,"given":"Kyriakie","family":"Sarafoglou","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN 55454, USA"},{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth I","family":"Pierpont","sequence":"additional","affiliation":[{"name":"Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Orchard","sequence":"additional","affiliation":[{"name":"Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN 55454, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,4,12]]},"reference":[{"issue":"6","key":"2022050521562712700_CIT0001","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1515\/jpem-2018-0445","article-title":"Etiology of primary adrenal insufficiency in children: a 29-year single-center experience","volume":"32","author":"Wijaya","year":"2019","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"6","key":"2022050521562712700_CIT0002","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/jc.2004-0016","article-title":"Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal","volume":"90","author":"Perry","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2022050521562712700_CIT0003","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.beem.2018.05.010","article-title":"Primary adrenal insufficiency in children: Diagnosis and management","volume":"32","author":"Kirkgoz","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"4","key":"2022050521562712700_CIT0004","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijns2040015","article-title":"Newborn screening for X-linked adrenoleukodystrophy","volume":"2","author":"Moser","year":"2016","journal-title":"Int. J. Neonatal Screen"},{"issue":"4","key":"2022050521562712700_CIT0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann Neurol."},{"issue":"10","key":"2022050521562712700_CIT0006","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy \u2013 neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol."},{"issue":"11","key":"2022050521562712700_CIT0007","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2018-00920","article-title":"Adrenoleukodystrophy: guidance for adrenal surveillance in males identified by newborn screen","volume":"103","author":"Regelmann","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2022050521562712700_CIT0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpneuro0421","article-title":"X-linked adrenoleukodystrophy","volume":"3","author":"Moser","year":"2007","journal-title":"Nat Clin Pract Neurol."},{"issue":"4","key":"2022050521562712700_CIT0009","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","article-title":"Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening","volume":"146","author":"Dubey","year":"2005","journal-title":"J Pediatr."},{"issue":"8","key":"2022050521562712700_CIT0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00431-011-1401-1","article-title":"Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison\u2019s disease improves survival and neurological outcomes","volume":"170","author":"Polgreen","year":"2011","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2022050521562712700_CIT0011","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR Am J Neuroradiol."},{"key":"2022050521562712700_CIT0012","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.1038\/s41598-020-71248-8","article-title":"Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-adrenoleukodystrophy","volume":"10","author":"Rattay","year":"2020","journal-title":"Sci Rep"},{"key":"2022050521562712700_CIT0013","year":"2021"},{"issue":"5","key":"2022050521562712700_CIT0014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00787-011-0161-9","article-title":"X-Linked adrenoleukodystrophy in a 7-year-old boy presenting with psychiatric symptoms","volume":"20","author":"G\u00fcler","year":"2011","journal-title":"Eur Child Adolesc Psychiatry."},{"issue":"2","key":"2022050521562712700_CIT0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0019-5545.158198","article-title":"X-linked adrenoleukodystrophy presenting as attention deficit hyperactivity disorder","volume":"57","author":"Ilango","year":"2015","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"2022050521562712700_CIT0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004703-199902000-00005","article-title":"Case studies: psychological test findings for two children with X-linked adrenoleukodystrophy","volume":"20","author":"Ievers","year":"1999","journal-title":"J Dev Behav Pediatr."},{"issue":"2","key":"2022050521562712700_CIT0017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2004.02561.x","article-title":"Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?","volume":"137","author":"Betterle","year":"2004","journal-title":"Clin Exp Immunol."},{"issue":"11","key":"2022050521562712700_CIT0018","first-page":"376","article-title":"Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review","volume":"67","author":"Van den Driessche","year":"2009","journal-title":"Neth J Med."},{"issue":"6","key":"2022050521562712700_CIT0019","doi-asserted-by":"crossref","first-page":"101344","DOI":"10.1016\/j.beem.2019.101344","article-title":"Autoimmune polyglandular diseases","volume":"33","author":"Kahaly","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"7","key":"2022050521562712700_CIT0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajmg.a.61171","article-title":"A report on state-wide implementation of newborn screening for X-linked Adrenoleukodystrophy","volume":"179","author":"Wiens","year":"2019","journal-title":"Am J Med Genet A"},{"issue":"4-5","key":"2022050521562712700_CIT0021","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.autrev.2014.01.025","article-title":"Diagnosis and classification of Addison\u2019s disease (autoimmune adrenalitis)","volume":"13","author":"Brand\u00e3o Neto","year":"2014","journal-title":"Autoimmun Rev."},{"issue":"7","key":"2022050521562712700_CIT0022","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2007-979803","article-title":"Absence of circulating adrenal autoantibodies in adult-onset X-linked adrenoleukodystrophy","volume":"28","author":"Laureti","year":"1996","journal-title":"Horm Metab Res"},{"issue":"2","key":"2022050521562712700_CIT0023","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2022050521562712700_CIT0024","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jpeds.2019.04.021","article-title":"Early onset primary adrenal insufficiency in males with adrenoleukodystrophy: case series and literature review","volume":"211","author":"Eng","year":"2019","journal-title":"J Pediatr."},{"issue":"3","key":"2022050521562712700_CIT0025","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jimd.12356","article-title":"MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines","volume":"44","author":"Mallack","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"2022050521562712700_CIT0026","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac039\/43368915\/bvac039.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/5\/bvac039\/43557596\/bvac039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/5\/bvac039\/43557596\/bvac039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T22:31:45Z","timestamp":1700433105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac039\/6567221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,12]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac039","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,4,12]]},"article-number":"bvac039"}}